SPL 6.06% 10.5¢ starpharma holdings limited

Ann: VIRALEZE Protects Against SARS-CoV-2 in Challenge Model, page-37

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,279 Posts.
    lightbulb Created with Sketch. 592
    again well done, some do sound a bit dismissive, but it all helps. I got worn out sending emails a couple of months ago... and with lack of reply, depressing.
    NSW state gov is now sounding political in their approach, and what now seems closed off agenda to vaccines being to only way forward... diappointing as did get some more meaningful replies a while ago, but that has waned.

    I sent one to the Cruise liner industry... seem to be a few governing bodies. imagine how they would be derisked if viraleze was part of a travel pass, and in every first aide kits.
    With varinats, like in Africa, combined with the UK and Israeli experience, waning vacs - or even whether vac will cover the variant is starting to hit the airways.... were have a big part to play.
    haven't read this article through yet...

    but like the headline and may provide extra info/noise for those great people sending out those emails as many will look to overseas examples of progress, and to where Viraleze will clearly fit in... i'm seek the agendas of Gov and must vac as a wall to viraleze approval.

    https://www.nature.com/articles/s41598-021-95699-9


 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.006(6.06%)
Mkt cap ! $43.90M
Open High Low Value Volume
10.0¢ 10.5¢ 10.0¢ $42.85K 414.4K

Buyers (Bids)

No. Vol. Price($)
1 10000 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 247015 5
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.